Data processing: measuring – calibrating – or testing – Measurement system in a specific environment – Chemical analysis
Reexamination Certificate
2006-03-28
2006-03-28
Allen, Marianne P. (Department: 1631)
Data processing: measuring, calibrating, or testing
Measurement system in a specific environment
Chemical analysis
C702S019000, C702S020000, C435S007200
Reexamination Certificate
active
07020563
ABSTRACT:
Identification of the human insulin receptor binding site sequence of certain spatial molecular structures conforming to such binding site and of certain insulinomimetic sequences including the binding site sequence are disclosed.
REFERENCES:
patent: 5705335 (1998-01-01), Hendry
patent: WO 90/00562 (1990-01-01), None
“Crystallization of the first three domains of the human insulin-like growth factor-1 receptor”, N. McKern et al., Protein Science (1997), No. 6, pp. 2663-2666.
“Crystal structure of the first three domains of the type-1 insulin-like growth factor receptor”, T. Garrett et al., Nature, vol. 394, Jul. 23, 1998, pp. 395-399.
Baserga, Renato, et al. “The IGF-I receptor in cell growth, transformation and apoptosis” Biochemica et Biophysica Acta, vol. 1332, Jun. 1997, pp. F105-F126.
Bentley John David
Cosgrove Leah Jane
Frenkel Maurice John
Garrett Thomas Peter John
Lawrence Lynne Jean
Allen Marianne P.
Commonwealth Scientific and Industrial Research Organisation
McDermott Will & Emery LLP
LandOfFree
Method of designing agonists and antagonists to IGF receptor does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of designing agonists and antagonists to IGF receptor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of designing agonists and antagonists to IGF receptor will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3575874